# Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

> **NCT00357630** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 52 (estimated)

## Conditions studied

- Carcinoma of Unknown Primary
- Pain

## Interventions

- **DRUG:** gemcitabine hydrochloride
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00357630
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-02
- **Final completion:** —
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2020-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357630, "Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00357630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*